News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,033 Results
Type
Article (5015)
Company Profile (18)
Press Release (220000)
Section
Business (82210)
Career Advice (461)
Deals (15043)
Drug Delivery (8)
Drug Development (19078)
Employer Resources (30)
FDA (3676)
Job Trends (3908)
News (120127)
Policy (7503)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14765)
ALS (19)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3692)
Artificial intelligence (40)
Autoimmune disease (3)
Automation (2)
Bankruptcy (97)
Best Places to Work (2871)
Biosimilars (11)
Biotechnology (22)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (438)
Cardiovascular disease (22)
Career advice (392)
Career pathing (2)
CAR-T (31)
Cell therapy (102)
Cervical cancer (2)
Clinical research (16026)
Collaboration (163)
Compensation (162)
Complete response letters (2)
COVID-19 (301)
CRISPR (7)
C-suite (99)
Cystic fibrosis (16)
Data (502)
Depression (5)
Diabetes (40)
Diagnostics (2039)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (13)
Earnings (40774)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37723)
Executive appointments (304)
FDA (3922)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (179)
Gene editing (15)
Generative AI (2)
Gene therapy (50)
GLP-1 (107)
Government (410)
Guidances (16)
Healthcare (5039)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7824)
IRA (3)
Job creations (1120)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (5)
Legal (2331)
Liver cancer (17)
Lung cancer (53)
Lymphoma (28)
Management (10)
Manufacturing (46)
MASH (27)
Medical device (3858)
Medtech (3859)
Mergers & acquisitions (7422)
Metabolic disorders (118)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (338)
NextGen: Class of 2025 (1675)
Non-profit (728)
Northern California (903)
Now hiring (2)
Obesity (52)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (14)
Parkinson's disease (26)
Partnered (4)
Patents (21)
Patient recruitment (27)
Peanut (5)
People (24576)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4781)
Phase II (6958)
Phase III (5545)
Pipeline (541)
Policy (7)
Postmarket research (625)
Preclinical (1870)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (66)
Real estate (1874)
Recruiting (8)
Regulatory (5114)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (25)
Series B (22)
Sickle cell disease (7)
Southern California (686)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1008)
Stomach cancer (1)
Supply chain (10)
Tariffs (3)
United States (6902)
Vaccines (36)
Venture capitalists (2)
Weight loss (20)
Women's health (1)
Date
Today (28)
Last 7 days (138)
Last 30 days (774)
Last 365 days (10101)
2025 (2815)
2024 (11037)
2023 (13205)
2022 (18666)
2021 (19687)
2020 (18238)
2019 (13206)
2018 (10205)
2017 (10001)
2016 (9156)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11440)
Australia (1606)
California (1896)
Canada (688)
China (70)
Colorado (80)
Connecticut (91)
Delaware (29)
Europe (24485)
Florida (267)
Georgia (33)
Idaho (23)
Illinois (111)
India (6)
Indiana (62)
Iowa (1)
Japan (66)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (218)
Massachusetts (1529)
Michigan (85)
Minnesota (137)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (15)
New Jersey (553)
New Mexico (5)
New York (466)
North Carolina (321)
North Dakota (2)
Northern California (903)
Ohio (55)
Oklahoma (5)
Oregon (3)
Pennsylvania (337)
Puerto Rico (1)
Rhode Island (12)
South America (276)
South Carolina (4)
Southern California (686)
Tennessee (38)
Texas (221)
Utah (59)
Virginia (43)
Washington D.C. (9)
Washington State (169)
West Virginia (2)
Wisconsin (21)
225,033 Results for "pepgen corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Duchenne Muscular Dystrophy
Déjà Vu for PepGen as FDA Places Hold on DMD Drug
The FDA has put a stop to U.S. initiation of PepGen’s Phase II trial for its Duchene muscular dystrophy treatment. The company faced the same hurdle for an earlier neuromuscular candidiate in 2023.
December 16, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference
April 2, 2025
·
1 min read
Press Releases
PepGen Announces Appointment of Two New Directors to its Board
April 1, 2025
·
3 min read
Press Releases
PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights
February 24, 2025
·
11 min read
Press Releases
PepGen to Participate in Upcoming March 2025 Investor Conferences
March 5, 2025
·
1 min read
Press Releases
PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
March 10, 2025
·
4 min read
Press Releases
PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD
March 5, 2025
·
7 min read
Business
PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today reported financial results and recent corporate highlights for the quarter ended March 31, 2024.
May 14, 2024
·
10 min read
Press Releases
PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
November 7, 2024
·
10 min read
Press Releases
PepGen to Participate in Upcoming Investor Conferences
November 4, 2024
·
1 min read
1 of 22,504
Next
